SCHEMBL8307213

SCHEMBL8307213

O=C1CC(CCOC2CC(c3ccc(Cl)c(Cl)c3)CCO2)CN1

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 3/20 0.34
SLC6A2 P23975 8/20 0.34
SLC6A3 Q01959 6/20 0.34
SLC6A4 P31645 6/20 0.34
CYP2D6 P10635 1/20 0.34
KCNH2 Q12809 1/20 0.34
PDE4A P27815 7/20 0.32
PDE4B Q07343 3/20 0.32
PDE4C Q08493 3/20 0.32
PDE4D Q08499 3/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
BACE1 P56817 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8483971 0.76 PTAFR (0.36) PTAFRSLC6A2SLC6A3SLC6A4CYP2D6
SCHEMBL8479446 0.73 TACR1 (0.33)
SCHEMBL8366455 0.72 PTAFR (0.36) PTAFRSLC6A2SLC6A3SLC6A4CYP2D6
SCHEMBL8478669 0.71 PTAFR (0.39) PTAFRSLC6A2SLC6A3SLC6A4CYP2D6
SCHEMBL8479038 0.70 PTAFR (0.44) PTAFRSLC6A2SLC6A3SLC6A4CYP2D6
SCHEMBL2155319 0.68 PDE4A (0.56) SLC6A2SLC6A3SLC6A4CYP2D6KCNH2
SCHEMBL8561220 0.68 MEN1 (0.39) PTAFRSLC6A2SLC6A3SLC6A4CYP2D6
SCHEMBL8366968 0.67 PTAFR (0.39) PTAFRSLC6A2SLC6A3SLC6A4CYP2D6
SCHEMBL8366957 0.66 PTAFR (0.44) PTAFRSLC6A2SLC6A3SLC6A4CYP2D6
SCHEMBL9272077 0.61 SLC6A2 (0.50) SLC6A2SLC6A3SLC6A4CYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0777666-B1 SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMA INC (US) 1999-03-03 EP disclosed
US-5859029-A TREATING SUBSTANCE P-DEPENDENT PATHOLOGICAL CONDITIONS SANOFI (FR) 1999-01-12 US disclosed